vimarsana.com

Page 8 - ஒன்றுபட்டது கிஂக்டம் பொது ஆரோக்கியம் இங்கிலாந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Our vaccine highly effective on Covid-19 variant prevalent in India, suitable for 12 years and above: Pfizer to Govt | India News

NEW DELHI: Seeking a fast-track approval for its Covid-19 vaccine, US major Pfizer has told Indian authorities that its jab has shown high effectiveness against the SARS-CoV-2 variant prevalent in India and on people of Indian ethnicity or nationality, while it is suitable for everyone aged 12 years or above and can be stored for a month at 2-8 degrees, sources said on Wednesday. Pfizer, which is ready to offer 5 crore doses to India between July and October this year and has sought certain relaxations including indemnification, has held a series of interactions with the Indian government authorities recently including one this week, during which it shared the most recent data points regarding efficacy trials and approvals for its vaccine in various countries and by the World Health Organisation (WHO).

Our vaccine highly effective on COVID-19 variant prevalent in India, suitable for 12 years and above: Pfizer to Govt

Pfizer, which is ready to offer 5 crore doses to India between July and October this year and has sought certain relaxations including indemnification, has held a series of interactions with the Indian government authorities recently including one this week, during which it shared the most recent data points regarding efficacy trials and approvals for its vaccine in various countries and by the WHO.

Pfizer says its vaccine works against COVID s B 1 617 strain, for 12+ age group & at 2-8°C

Last Updated: 26th May, 2021 23:44 IST Pfizer Says Its Vaccine Works Against COVID s B.1.617 Strain, For 12+ Age Group & At 2-8°C Pfizer told Indian authorities that its jab has shown high effectiveness against the SARS-CoV-2 variant prevalent in India or on people of Indian ethnicity Image Credits: PTI/AP As India continues to ramp up indigenous production of anti-Coronavirus jabs, vaccine giant Pfizer recently offered their COVID-19 vaccine to India. Now, Pfizer has told Indian authorities that its jab has shown high effectiveness against the SARS-CoV-2 variant prevalent in India and on people of Indian ethnicity or nationality, while it is suitable for everyone aged 12 years or above and can be stored for a month at 2-8 degrees, sources said on Wednesday. The 2-8 degrees storage is a gamechanger as previously the vaccine was said to only be storable at a much lower temperature that s colder than most standard refrigerators and cold storage can provide.

Our vaccine highly effective on COVID-19 variant prevalent in India, suitable for 12 years and above- The New Indian Express

Our vaccine highly effective on COVID-19 variant prevalent in India, suitable for 12 years and above: Pfizer to government The data shared with Indian authorities include real-world evidence of BNT162b2 vaccine effectiveness and safety from national immunization programmes. Share Via Email   |  A+A A- By PTI NEW DELHI: Seeking a fast-track approval for its COVID-19 vaccine, US major Pfizer has told Indian authorities that its jab has shown high effectiveness against the SARS-CoV-2 variant prevalent in India and on people of Indian ethnicity or nationality, while it is suitable for everyone aged 12 years or above and can be stored for a month at 2-8 degrees, sources said on Wednesday.

Pfizer seeks fast-track approval, tells govt its vaccine is highly effective on variant prevalent in India

Pfizer seeks fast-track approval, tells govt its vaccine is highly effective on variant prevalent in India Pfizer has sought a fast-track approval for its Covid-19 vaccine, stating that the vaccine is highly effective against the variant prevalent in India. advertisement UPDATED: May 27, 2021 07:41 IST Pfizer said its vaccine is suitable for everyone aged 12 years or above and can be stored for a month at 2-8 degrees. (Photo: Reuters) US pharma giant Pfizer on Wednesday told the central government that its Covid-19 vaccine is highly effective against the Covid-19 variant that is prevalent in India. Pfizer has also reportedly sought fast-track approval of its vaccine.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.